Laser capture microdissection shows HPV11 as both a causal and a coincidental infection in cervical cancer specimens with multiple HPV types

Histopathology

Volumn 63, Issue 2, 2013, Pages 287-292

  Guimerà, Núria ^a,b   Lloveras, Belen ^b,c   Alemany, Laia ^b,d   Iljazovic, Ermina ^e   Shin, Hai Rim ^f   Jung Il, Suh ^g   de Sanjose, Silvia ^b,d   Jenkins, David ^a   Bosch, F Xavier ^b   Quint, Wim ^a  

^a DDL DIAGNOSTIC LABORATORY   (Netherlands)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e University Clinical Centre   (Bosnia and Herzegovina)

^f National Cancer Center   (South Korea)

^g National Medical Center   (South Korea)

Author keywords

HPV11; Low risk HPV; Multiple HPV infections

Indexed keywords

PROTEIN P16;

ADULT; ARTICLE; CARCINOGENICITY; CASE REPORT; EOSINOPHIL; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 31; IMMUNOREACTIVITY; KERATINIZATION; LASER CAPTURE MICRODISSECTION; MIXED INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL; TISSUE SECTION; UTERINE CERVIX CANCER;

HUMAN PAPILLOMAVIRUS;

EID: 84880758813     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12137     Document Type: Article

References (20)

1. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999; 189; 12-19.
2. Bosch FX, de SS. Human papillomavirus in cervical cancer. Curr. Oncol. Rep. 2002; 4; 175-183.
3. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370(890-90); 7.
4. de Sanjose S, Quint WG, Alemany L et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010; 11; 1048-1056.
5. Cuschieri KS, Cubie HA, Whitley MW et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J. Clin. Pathol. 2004; 57; 68-72.
6. Guan P, Howell-Jones R, Li N et al. Human papillomavirus types in 115, 789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int. J. Cancer 2012; 131; 2349-2359.
7. Bouvard V, Baan R, Straif K et al. A review of human carcinogens-part B: biological agents. Lancet Oncol. 2009; 10; 321-322.
8. Quint W, Jenkins D, Molijn A et al. One virus, one lesion-individual components of CIN lesions contain a specific HPV type. J. Pathol. 2012; 227; 62-71.
9. Richardson H, Kelsall G, Tellier P et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol. Biomarkers Prev. 2003; 12; 485-490.
10. Kalantari M, Garcia-Carranca A, Morales-Vazquez CD et al. Laser capture microdissection of cervical human papillomavirus infections: copy number of the virus in cancerous and normal tissue and heterogeneous DNA methylation. Virology 2009; 390; 261-267.
11. Guimerà N, Lloveras B, Lindeman J et al. The occasional role of low risk human papillomaviruses 6, 11, 42, 44 and 70 in anogenital carcinoma defined by laser capture microdissection/PCR methodology. Results from a global study. Am. J. Surg. Pathol. 2013; In press.
12. Mulvany NJ, Allen DG, Wilson SM. Diagnostic utility of p16ink4a: a reappraisal of its use in cervical biopsies. Pathology 2008; 40; 335-344.
13. Tavassoéli FA, Devilee P eds. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press, 2003.
14. Kleter B, van Doorn LJ, Ter SJ et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am. J. Pathol. 1998; 153; 1731-1739.
15. Kleter B, van Doorn LJ, Schrauwen L et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J. Clin. Microbiol. 1999; 37; 2508-2517.
16. Gillison ML, Alemany L, Snijders PJ et al. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine 2012; 30(Suppl. 5); F34-F54.
17. Barzon L, Militello V, Pagni S et al. Distribution of human papillomavirus types in the anogenital tract of females and males. J. Med. Virol. 2010; 82; 1424-1430.
18. Chan PK, Luk AC, Luk TN et al. Distribution of human papillomavirus types in anogenital warts of men. J. Clin. Virol. 2009; 44; 111-114.
19. Gissmann L, Diehl V, Schultz-Coulon HJ, zur Hausen H. Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J. Virol. 1982; 44; 393-400.
20. Rabah R, Lancaster WD, Thomas R, Gregoire L. Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr. Dev. Pathol. 2001; 4; 68-72.